Latest Ratios: P/E Ratio -2.6x · EV/EBITDA N/A · ROE N/A. (2017–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $53M | $41M | $268M | $567M | $221M | $157M | $602M | $1.2B | — | — |
| Enterprise Value | $57M | $45M | $263M | $558M | $208M | $146M | $580M | $1.2B | — | — |
| P/E Ratio → | -2.65 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | 4.60 | 6.06 | 3.16 | 2.88 | 9.41 | 10.46 | — | — |
| P/B Ratio | — | — | — | 25.36 | 11.03 | 8.43 | 21.20 | 47.62 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 4.51 | 5.96 | 2.98 | 2.68 | 9.07 | 10.45 | — | — |
| EV / EBITDA | — | — | — | 205.19 | — | — | — | — | — | — |
| EV / EBIT | — | — | — | 1865.95 | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 17.0% | 20.6% | 16.6% | 11.8% | 23.8% | 29.7% | 35.4% | 34.4% |
| Operating Margin | — | — | -57.7% | 0.5% | -20.5% | -69.6% | -45.7% | -19.3% | 4.0% | -11.5% |
| Net Profit Margin | — | — | -57.7% | -0.1% | -20.2% | -70.8% | -46.8% | -22.2% | 0.9% | -14.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | -403.7% | -0.4% | -72.8% | -164.2% | -111.0% | -168.6% | 24.9% | — |
| ROA | -49.4% | -49.4% | -70.3% | -0.2% | -29.7% | -84.5% | -56.6% | -42.1% | 2.6% | -28.2% |
| ROIC | — | — | -2544.6% | 3.8% | -146.3% | -400.2% | -141.4% | -111.9% | 156.2% | — |
| ROCE | — | — | -338.2% | 2.3% | -68.5% | -152.2% | -101.4% | -95.3% | 50.5% | -305.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | 0.00 | 0.01 | 0.01 | 0.01 | 0.40 | 2.63 | — |
| Debt / EBITDA | — | — | — | 0.02 | — | — | — | — | 1.86 | — |
| Net Debt / Equity | — | — | — | -0.42 | -0.65 | -0.59 | -0.77 | -0.04 | 0.09 | — |
| Net Debt / EBITDA | — | — | — | -3.44 | — | — | — | — | 0.06 | — |
| Debt / FCF | — | — | — | — | — | — | — | — | 0.35 | — |
| Interest Coverage | -4.35 | -4.35 | -1151.48 | 19.93 | -142.33 | — | -39.12 | -15.06 | 2.11 | -9.23 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.60 | 0.60 | 0.74 | 1.36 | 1.36 | 1.70 | 2.23 | 1.71 | 1.33 | 0.98 |
| Quick Ratio | 0.60 | 0.60 | 0.49 | 1.16 | 1.24 | 1.44 | 1.67 | 1.01 | 0.87 | 0.66 |
| Cash Ratio | 0.03 | 0.03 | 0.12 | 0.29 | 0.41 | 0.54 | 1.08 | 0.41 | 0.27 | 0.06 |
| Asset Turnover | — | — | 1.47 | 1.67 | 1.30 | 1.33 | 1.27 | 2.10 | 2.01 | 1.95 |
| Inventory Turnover | — | — | 4.55 | 11.40 | 14.89 | 8.69 | 4.30 | 4.19 | 4.01 | 4.31 |
| Days Sales Outstanding | — | — | 72.87 | 102.39 | 129.36 | 98.66 | 29.17 | 35.98 | 57.68 | 75.21 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $13M | $5M | $4M | $3M | $946456 | $462086 | $186036 | $34473 | $10266 |
Imminent liquidity and solvency
As reported in financial statements, Sonim's gross margins have exhibited extreme instability, ranging from a peak of 50% in 2025Q1 to a negative 1.2% in 2024Q4, which suggests a lack of pricing power and high sensitivity to carrier-driven inventory adjustments and component cost fluctuations.
The erratic nature of these margins indicates that the company struggles to maintain consistent profitability in its hardware-centric model. Investors should monitor whether the recent pivot toward barcode scanning can stabilize these fluctuations or if the business remains structurally tethered to low-margin carrier hardware cycles.
Based on the provided quarterly data, the company's cash conversion cycle has fluctuated significantly, with DSO reaching as high as 199 days in 2023Q4, indicating that Sonim faces substantial challenges in collecting receivables and managing its operational efficiency relative to its historical performance.
High DSO levels suggest that the company may be offering extended payment terms to Tier 1 carriers to maintain its shelf space, which ties up critical liquidity. This inefficiency appears to be a structural drag on the company's ability to self-fund its operations.
According to recent SEC filings, the company's current ratio has deteriorated to 0.76 as of 2026Q1, which, when paired with a cash balance of only $1.3 million, suggests a severe liquidity shortfall that may necessitate immediate external financing to sustain ongoing business operations.
The current ratio falling below unity implies that current liabilities exceed current assets, leaving little margin for error in the event of further operational setbacks. This liquidity position warrants extreme caution, as it limits the company's ability to navigate even minor supply chain or demand-side disruptions.
As noted in historical financial filings, the market's reliance on P/S multiples for Sonim is fundamentally flawed, as the company's revenue recognition is highly susceptible to lumpy carrier sell-in cycles and contra-revenue adjustments that obscure the underlying health of the core ruggedized hardware business.
Investors should instead focus on cash-burn rates and liquidity runway, as these metrics provide a more accurate assessment of the company's survival risk. Using traditional valuation multiples in the current context of near-zero revenue growth may lead to a significant mispricing of the company's distressed asset value.
Includes 30+ ratios · 9 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SONM stock.
DNA X, Inc.'s current P/E ratio is -2.6x. This places it at the 50th percentile of its historical range.
Based on historical data, DNA X, Inc. is trading at a P/E of -2.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.